Menten, P., Struyf, S., Schutyser, E., Wuyts, A., De Clercq, E., Schols, D., . . . Van Damme, J. (1999). The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine. American Society for Clinical Investigation.
Styl cytowania ChicagoMenten, Patricia, Sofie Struyf, Evemie Schutyser, Anja Wuyts, Erik De Clercq, Dominique Schols, Paul Proost, i Jo Van Damme. The LD78β Isoform of MIP-1α Is the Most Potent CCR5 Agonist and HIV-1–inhibiting Chemokine. American Society for Clinical Investigation, 1999.
Styl cytowania MLAMenten, Patricia, et al. The LD78β Isoform of MIP-1α Is the Most Potent CCR5 Agonist and HIV-1–inhibiting Chemokine. American Society for Clinical Investigation, 1999.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..